06-05-2025 12:45 via drugs.com

RSV Antibody Treatment Effective For Babies

TUESDAY, May 6, 2025-- Newborns can be effectively protected against respiratory syncytial virus (RSV) infection through the use of nirsevimab, a monoclonal antibody treatment, researchers report.Babies treated with nirsevimab had an 83% reduced...
Read more »

Pharmaceutical news



Europe Launches $565 Million Campaign to Attract U.S. Scientists
Food Choices Could Influence First Period, Research Shows
Nicotine Pouch Use Doubles Among U.S. High Schoolers
Conversion Therapy Harms Heart Health
Stress Quadruples Risk Of COPD Flares, Study Says
Shingles Vaccine Could Protect Heart Health
Childhood High Blood Sugar Can Cause Heart Problems In Young Adults
Obtaining Second Opinion Delays Treatment for Breast Cancer, but Not Appreciably
No Increase Seen in Risk for Incident Diverticulitis With Nuts, Seeds, Corn Intake
FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities
72 Percent of Infants Immunized Against Respiratory Syncytial Virus
One in 10 U.S. Internal Medicine Doctors Report High Degree of Burnout
Higher Stress Tied to Worse Respiratory Outcomes With COPD
Hormone Therapy Tied to Worse Bladder Health in Postmenopausal Women
Desktop versie